Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong growth prospects in key areas such as data center computing, with the Thailand facility poised to support substantial expansion. Despite cautious guidance due to supply chain concerns and market uncertainties, the company expects revenue growth, margin improvement, and substantial contributions from new products. The active M&A pipeline and strategic inventory management further bolster confidence. Considering the market cap, the stock is likely to react positively, though the cautious approach to guidance tempers expectations for a stronger rally.
Revenue (Q4 2025) $489 million, increased 6% sequentially and 18% year-over-year. Growth driven by strengthening demand in semiconductor, Industrial & Medical markets, and record data center revenue.
Gross Margin (Q4 2025) 39.7%, up 60 basis points sequentially and 240 basis points year-over-year. Improvement due to higher volume, favorable product mix, and operational efficiencies despite tariff impacts.
Earnings Per Share (Q4 2025) $1.94, up from $1.74 in the previous quarter and $1.30 a year ago. Growth attributed to higher revenue and improved margins.
Data Center Computing Revenue (Q4 2025) $178 million, up 4% sequentially and 101% year-over-year. Growth driven by strong demand and adjustments to product mix.
Semiconductor Revenue (Q4 2025) $212 million, up 8% sequentially and 6% year-over-year. Growth due to stronger customer demand and new product contributions.
Industrial & Medical Revenue (Q4 2025) $78 million, up 10% sequentially and 2% year-over-year. Growth attributed to improving supply-demand dynamics and lower inventories.
Operating Margin (Q4 2025) 17.8%, up 100 basis points sequentially and 430 basis points year-over-year. Improvement due to leverage in financial model and disciplined spending.
Operating Cash Flow (2025) $235 million, a record high. Growth driven by improved days of net working capital and strong revenue performance.
Revenue (Full Year 2025) $1.8 billion, up 21% year-over-year. Growth driven by 107% increase in data center computing revenue and 6% increase in semiconductor revenue.
Gross Margin (Full Year 2025) 38.7%, up 240 basis points year-over-year. Improvement due to operational efficiencies and higher revenue leverage despite tariff impacts.
Earnings Per Share (Full Year 2025) $6.41, up 73% year-over-year. Growth attributed to higher revenue, improved margins, and disciplined spending.
Data Center Computing Revenue (Full Year 2025) $587 million, up 107% year-over-year. Growth driven by adoption of customized power solutions in AI rack applications.
Semiconductor Revenue (Full Year 2025) $840 million, up 6% year-over-year. Growth due to new product contributions and strong customer demand.
Industrial & Medical Revenue (Full Year 2025) Decreased 11% year-over-year. Decline due to prolonged inventory correction, though sequential growth occurred in later quarters.
Operating Margin (Full Year 2025) 15.8%, up 560 basis points year-over-year. Improvement due to higher revenue leverage and disciplined spending.
New Product Launches: 26 new products launched across markets in 2025, including custom products.
Semiconductor Technologies: Positive feedback on eVerest, eVoS, and NavX technologies, delivering improvements in yield and throughput. Multiple design wins and development projects underway for 2026.
Data Center Products: Customized power solutions adopted for AI rack applications. New technologies and products for next-gen AI data centers under development.
Industrial & Medical Products: Investments in new products, customization, and digital marketing to leverage market recovery.
Data Center Market: Revenue more than doubled in 2025, with over 30% growth projected for 2026. Modular technology and design speed are key enablers.
Semiconductor Market: Revenue grew 6% in 2025, with stronger forecasts for 2026 driven by advanced logic and memory capacity investments.
Industrial & Medical Market: Sequential revenue growth in 2025 after a decline. Continued improvement expected in 2026 due to normalized inventories and new product adoption.
Manufacturing Expansion: Capacity expanded in the Philippines and Mexico. New Thailand factory fit-up completed, enabling $1 billion in annual revenue capacity.
Gross Margin Improvement: Expanded by 240 basis points in 2025, with a target of 40% in 2026.
Operational Cash Flow: Record $235 million in 2025, funding production capacity investments.
Diversification Strategy: Focus on multiple high-value markets to deliver consistent financial results.
Inorganic Growth: Plans to pursue acquisitions to broaden technology portfolio and scale.
R&D and Marketing Investments: Increased spending to build a strong product portfolio and grow the design win pipeline.
Tariff Impact: Ongoing tariff headwinds have impacted gross margins, though the company has managed to limit the impact to less than 100 basis points. This remains a challenge for achieving long-term gross margin goals.
Manufacturing Footprint Optimization: The company exited its last manufacturing facility in China and expanded capacity in the Philippines, Mexico, and Thailand. While this improves capacity, it also introduces risks related to operational efficiency and potential delays in ramping up new facilities.
Inventory Management: Inventory days remain high at 125, and the company expects inventory to increase further to support growth and strategic supply. This could tie up working capital and increase risks of obsolescence.
Economic Conditions in Industrial & Medical Markets: Growth in the Industrial & Medical market is paced by overall economic conditions, which remain uncertain. This could impact demand recovery and new product adoption.
Product Mix and Volume Dependency: Achieving gross margin targets is dependent on product mix and volume, which introduces uncertainty in meeting financial goals.
Capital Expenditure: High levels of capital expenditure are required to complete the Thailand factory and other capacity expansions. This could strain cash flow if revenue growth does not materialize as expected.
Regulatory and Compliance Risks: The company operates in multiple regions with varying regulatory requirements, which could pose compliance challenges and increase operational costs.
2026 Revenue Growth: Projected to grow in the high teens, following 21% growth in 2025.
Semiconductor Market: Stronger customer forecasts and downstream investments in advanced logic and memory capacity are expected to drive growth, particularly in the second half of 2026. New product revenue is also expected to grow throughout the year.
Data Center Market: Full-year revenue is projected to grow more than 30%, supported by modular technology blocks, strong design teams, and development speed. Revenue is expected to strengthen through the year with new program production ramps.
Industrial & Medical Market: Demand is expected to improve over the next few quarters, with production revenue from wins in factory automation and defense enabling market outperformance.
Gross Margin: Expected to reach 40% in 2026, with a long-term goal of 43%, driven by improved manufacturing efficiency, a growing mix of new products, and higher revenue.
Capital Expenditures (CapEx): 2026 CapEx will continue at Q4 2025 levels, enabling over $2.5 billion of revenue-generating capacity within the existing footprint. The complete build-out of the Thailand factory will add an additional $1 billion of capacity. Longer-term CapEx is expected to revert to historical levels of around 4% of sales.
Thailand Factory: Expected to deliver more than $1 billion in annual revenue-generating capacity once fully built out.
Dividends Paid: During the quarter, we paid $4 million in dividends.
Share Repurchase: We spent $6.7 million to repurchase 33,000 shares at $205.38 per share.
The earnings call indicates strong growth prospects in key areas such as data center computing, with the Thailand facility poised to support substantial expansion. Despite cautious guidance due to supply chain concerns and market uncertainties, the company expects revenue growth, margin improvement, and substantial contributions from new products. The active M&A pipeline and strategic inventory management further bolster confidence. Considering the market cap, the stock is likely to react positively, though the cautious approach to guidance tempers expectations for a stronger rally.
The earnings call presents a strong growth outlook with a projected 17% revenue growth for 2025, driven by significant increases in data center and semiconductor markets. Despite some unclear responses, the company shows readiness for expansion with new facilities and strategic acquisitions. The positive guidance and strong financial health, alongside a focus on high-margin products and market share gains, suggest a positive stock price movement. However, the market cap indicates a moderate reaction, leading to a 'Positive' prediction of 2% to 8% increase over two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.